Future Vision II Acquisition Corporation Units

NASDAQ:FVNNU USA Shell Companies
Market Cap
$96.60K
Market Cap Rank
#20901 Global
#7547 in USA
Share Price
$10.70
Change (1 day)
+0.00%
52-Week Range
$10.20 - $14.95
All Time High
$14.95
About

Future Vision II Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Future Vision II Acquisition Corp. was incorporated in 2024 and is headquartered in Shanghai, China.

Future Vision II Acquisition Corporation Units (FVNNU) - Net Assets

Latest net assets as of December 2025: $61.90 Million USD

Based on the latest financial reports, Future Vision II Acquisition Corporation Units (FVNNU) has net assets worth $61.90 Million USD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($62.06 Million) and total liabilities ($158.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $61.90 Million
% of Total Assets 99.75%
Annual Growth Rate 705.68%
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

Future Vision II Acquisition Corporation Units - Net Assets Trend (2024–2025)

This chart illustrates how Future Vision II Acquisition Corporation Units's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Future Vision II Acquisition Corporation Units (2024–2025)

The table below shows the annual net assets of Future Vision II Acquisition Corporation Units from 2024 to 2025.

Year Net Assets Change
2025-12-31 $61.90 Million +704.53%
2024-12-31 $7.69 Million --

Equity Component Analysis

This analysis shows how different components contribute to Future Vision II Acquisition Corporation Units's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock $122.16 Million 6769.57%
Total Equity $1.80 Million 100.00%

Future Vision II Acquisition Corporation Units Competitors by Market Cap

The table below lists competitors of Future Vision II Acquisition Corporation Units ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Future Vision II Acquisition Corporation Units's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 7,694,207 to 1,804,521, a change of -5,889,686 (-76.5%).
  • Net income of 2,070,450 contributed positively to equity growth.
  • Other factors decreased equity by 7,960,136.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $2.07 Million +114.74%
Other Changes $-7.96 Million -441.12%
Total Change $- -76.55%

Book Value vs Market Value Analysis

This analysis compares Future Vision II Acquisition Corporation Units's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 34.09x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 2.59x to 34.09x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2024-12-31 $4.13 $10.70 x
2025-12-31 $0.31 $10.70 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Future Vision II Acquisition Corporation Units utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 114.74%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 34.39x
  • Recent ROE (114.74%) is above the historical average (63.48%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2024 12.22% 0.00% 0.00x 7.79x $171.06K
2025 114.74% 0.00% 0.00x 34.39x $1.89 Million

Industry Comparison

This section compares Future Vision II Acquisition Corporation Units's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Future Vision II Acquisition Corporation Units (FVNNU) $61.90 Million 12.22% 0.00x $53.76 Million
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K